Composition
Each film coated tablet contains: Erlotinib Hydrochloride equivalent to Erlotinib 150mg Excipients q.s. Colour: Titanium dioxide Red Oxide of Iron Yellow Oxide of Iron
Each film coated tablet contains: Erlotinib Hydrochloride 100mg equivalent to Erlotinib q.s. Excipients Colour: Titanium dioxide Red Oxide of Iron Yellow Oxide of Iron
INDICATIONS AND USAGE
Non-Small Cell Lung Cancer: Erlotinib is indicated for the treatment of patients with locally advanced or metastatic Non-Small Cell Lung Cancer after failure of at least one prior chemotherapy regimen.
Pancreatic Cancer Erlotinib in combination with Gemcitabine is indicated for the first-line treatment of patients with locally advanced, unresectable or metastatic Pancreatic Cancer.